Literature DB >> 6469748

Glutathione depletion in tissues after administration of buthionine sulphoximine.

A I Minchinton, A Rojas, K A Smith, J A Soranson, D C Shrieve, N R Jones, J C Bremner.   

Abstract

Buthionine sulphoximine (BSO) an inhibitor of glutathione (GSH) biosynthesis, was administered to mice in single and repeated doses of 0.5, 1 and 5 mmol kg-1 (i.p.). The resultant pattern of GSH depletion was studied in liver, kidney, skeletal muscle and three types of murine tumor. Liver and kidney exhibited a rapid depletion to GSH levels of ca. 20% of controls after single doses of 1-5 mmol kg-1 BSO. Muscle was depleted to a similar level, but at a slower rate after a single dose. All three tumors required repeated administration of BSO over several days to obtain a similar degree of depletion to that shown in the other tissues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469748     DOI: 10.1016/0360-3016(84)90329-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

2.  Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester.

Authors:  J Mårtensson; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Melphalan-induced toxicity in nude mice following pretreatment with buthionine sulfoximine.

Authors:  S X Skapek; A F VanDellen; D P McMahon; D G Postels; O W Griffith; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium.

Authors:  Gerald P Guntle; Bhumasamudram Jagadish; Eugene A Mash; Garth Powis; Robert T Dorr; Natarajan Raghunand
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

6.  Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.

Authors:  I D Ordoñez; E Cadenas
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.

Authors:  R T Dorr; J D Liddil; M J Soble
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

8.  Changes in cardiac electrophysiology, morphology, tissue biochemistry and vascular reactions in glutathione depleted animals.

Authors:  P Pacher; V Kecskemeti; A Z Ronai; I Balogh; G Szalai; B Matkovics
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

9.  Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx.

Authors:  F J Staal; M T Anderson; G E Staal; L A Herzenberg; C Gitler; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Enhanced cytostatic activity of the sesquiterpene lactone eupatoriopicrin by glutathione depletion.

Authors:  H J Woerdenbag; W Lemstra; T M Malingré; A W Konings
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.